Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - BIO-TECHNE Corp | ex_122664.htm |
| EX-31.2 - EXHIBIT 31.2 - BIO-TECHNE Corp | ex_122662.htm |
| EX-31.1 - EXHIBIT 31.1 - BIO-TECHNE Corp | ex_122661.htm |
| EX-23 - EXHIBIT 23 - BIO-TECHNE Corp | ex_122660.htm |
| EX-21 - EXHIBIT 21 - BIO-TECHNE Corp | ex_122876.htm |
| EX-10.9 - EXHIBIT 10.9 - BIO-TECHNE Corp | ex_122659.htm |
| EX-10.8 - EXHIBIT 10.8 - BIO-TECHNE Corp | ex_122658.htm |
| 10-K - FORM 10-K - BIO-TECHNE Corp | tech20180630_10k.htm |
Exhibit 32.1
BIO-TECHNE CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Bio-Techne Corporation (the “Company”) on Form 10-K for the year ended June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles Kummeth, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Charles Kummeth
Charles Kummeth
Chief Executive Officer
August 27, 2018